VistaGen names Douglas J. Williamson to board of directors

Reuters2026/07/31 12:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

VistaGen named Douglas J. Williamson to its board of directors.
Williamson is a CNS drug development consultant, founder of Destiny Biopharm Consulting, most recently chief medical officer at QurAlis.
He previously led R&D at Acadia Pharmaceuticals, served as chief medical officer at Avadel, held senior roles at Lundbeck, Parexel, and Eli Lilly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607310830PRIMZONEFULLFEED9801229) on July 31, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

VistaGen names Douglas J. Williamson to board of directors

You may also like

Crypto prices